ES513171A0 - Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias. - Google Patents

Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias.

Info

Publication number
ES513171A0
ES513171A0 ES513171A ES513171A ES513171A0 ES 513171 A0 ES513171 A0 ES 513171A0 ES 513171 A ES513171 A ES 513171A ES 513171 A ES513171 A ES 513171A ES 513171 A0 ES513171 A0 ES 513171A0
Authority
ES
Spain
Prior art keywords
factor
activity
vii
hemophilia
coagulation factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES513171A
Other languages
English (en)
Other versions
ES8304799A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22547053&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES513171(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of ES8304799A1 publication Critical patent/ES8304799A1/es
Publication of ES513171A0 publication Critical patent/ES513171A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
ES513171A 1980-05-27 1982-06-16 Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias. Granted ES513171A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15339680A 1980-05-27 1980-05-27

Publications (2)

Publication Number Publication Date
ES8304799A1 ES8304799A1 (es) 1983-03-16
ES513171A0 true ES513171A0 (es) 1983-03-16

Family

ID=22547053

Family Applications (2)

Application Number Title Priority Date Filing Date
ES502498A Granted ES502498A0 (es) 1980-05-27 1981-05-26 Procedimiento para preparar un complejo de coagulacion san- guinea
ES513171A Granted ES513171A0 (es) 1980-05-27 1982-06-16 Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES502498A Granted ES502498A0 (es) 1980-05-27 1981-05-26 Procedimiento para preparar un complejo de coagulacion san- guinea

Country Status (6)

Country Link
EP (1) EP0041174B1 (es)
JP (1) JPS5711924A (es)
AT (1) ATE15489T1 (es)
CA (1) CA1170183A (es)
DE (1) DE3172210D1 (es)
ES (2) ES502498A0 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
DE3826792C1 (es) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3914869C1 (es) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen

Also Published As

Publication number Publication date
ES8304799A1 (es) 1983-03-16
ATE15489T1 (de) 1985-09-15
ES8300017A1 (es) 1982-10-01
DE3172210D1 (en) 1985-10-17
ES502498A0 (es) 1982-10-01
CA1170183A (en) 1984-07-03
EP0041174A1 (en) 1981-12-09
EP0041174B1 (en) 1985-09-11
JPS5711924A (en) 1982-01-21

Similar Documents

Publication Publication Date Title
US5143838A (en) Method of producing thrombin from factor ii using calcium ions for the conversion on an anion exchanger
EP0541507A2 (de) Thrombin sowie Verfahren zu seiner Herstellung
EP0439156B1 (en) Process for the production of thrombin and high purity thrombin preparation thereby obtained
Berenberg et al. Chemotactic factor inactivator in normal human serum
Marciniak Factor‐Xa Inactivation by Antithrombin III: Evidence for Biological Stabilization of Factor Xa by Factor V–Phospholipid Complex
US4327086A (en) Process for heat treatment of aqueous solution containing human blood coagulation factor XIII
US3842061A (en) Method for isolation of antithrombin from animal tissue materials by adsorption on sulfated carbohydrate gel
US5831026A (en) Process for purifying factor VIII
JPH0150208B2 (es)
EP0230945A3 (en) Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same
DE3165965D1 (en) Blood-coagulation-promoting products and methods of preparing them
GR3025889T3 (en) Process of preparation of a human thrombin concentrate for therapeutic use
US4470969A (en) Process for producing a concentrate of coagulation factors VII and VIIa
CA2248960A1 (en) Stable factor viii/vwf-complex
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
ES513171A0 (es) Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias.
Depaoli-Roach et al. Calcium and calmodulin activation of muscle phosphorylase kinase: effect of tryptic proteolysis
US4510084A (en) Method of producing an antithrombin III-heparin concentrate or antithrombin III-heparinoid concentrate
KR930009612A (ko) 바이러스-유리된 트롬빈 농축물 제조방법
AT406865B (de) Verfahren zur trennung und gewinnung von rekombinantem pro-faktor ix von rekombinantem faktor ix
EP0565512B1 (de) Verfahren zur Aktivierung von Blutgerinnungsfaktoren
DE69433875D1 (de) Verfahren zur präparation von humanem aktiviertem protein c
Takahashi et al. Thrombospondin fragmentation by α-thrombin and resistance to γ-thrombin
KR920700220A (ko) 활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질c
Jacobs et al. Contact activation of factor XI